Related references
Note: Only part of the references are listed.Development of Extraintestinal Manifestations in Pediatric Patients with Inflammatory Bowel Disease
Folashade Adebisi Jose et al.
INFLAMMATORY BOWEL DISEASES (2009)
Imaging of orbital myositis in Crohn's disease
Joana Ramalho et al.
CLINICAL IMAGING (2008)
A common genetic background for inflammatory bowel disease and ankylosing spondylitis -: A genealogic study in Iceland
Bjarni Thjodleifsson et al.
ARTHRITIS AND RHEUMATISM (2007)
Effectiveness of adalimumab for rheumatoid arthritis in patients with a history of TNF-antagonist therapy in clinical practice
S. Bombardieri et al.
RHEUMATOLOGY (2007)
Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti-tumor necrosis factor α agents
J. Braun et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
Antibodies against cyclic citrullinated peptide (CCP) in inflammatory bowel disease patients with or without arthritic manifestations
Ioannis E. Koutroubakis et al.
INFLAMMATORY BOWEL DISEASES (2007)
The ocular manifestations of inflammatory bowel disease
Simon R. J. Taylor et al.
CURRENT OPINION IN OPHTHALMOLOGY (2006)
Orbital inflammatory disease: a diagnostic and therapeutic challenge
L. K. Gordon
EYE (2006)
Citrullination is an inflammation-dependent process
D. Makrygiannakis et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Efficacy and safety of adalimumab in patients with ankylosing spondylitis - Results of a multicenter, randomized, double-blind, placebo-controlled trial
Desiree van der Heijde et al.
ARTHRITIS AND RHEUMATISM (2006)
The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease
N Turkcapar et al.
RHEUMATOLOGY INTERNATIONAL (2006)
Revisiting the immunomodulators tacrolimus, methotrexate, and mycophenolate mofetil: Their mechanisms of action and role in the treatment of IBD
JM van Dieren et al.
INFLAMMATORY BOWEL DISEASES (2006)
Efficacy and safety of switching from infliximab to adalimumab: a comparative controlled study
SN Nikas et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period
JJ Gomez-Reino et al.
ARTHRITIS RESEARCH & THERAPY (2006)
The clustering of other chronic inflammatory diseases in inflammatory bowel disease: A population-based study
CN Bernstein et al.
GASTROENTEROLOGY (2005)
Assessment of acute spinal inflammation in patients with ankylosing spondylitis by magnetic resonance imaging:: a comparison between contrast enhanced T1 and short tau inversion recovery (STIR) sequences
X Baraliakos et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss
AR Moschen et al.
GUT (2005)
Rhabdomyolysis associated with Crohn's disease, probably mediated by myositis
T Matsuda et al.
ANESTHESIA AND ANALGESIA (2005)
Successful treatment with adalimumab in infliximab-resistant Crohn's disease
HR Barthel et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
Safety and efficacy of adalimumab (D2E7) in Crohn's disease patients with an attenuated response to infliximab
KA Papadakis et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use: a population based cohort study
T Card et al.
GUT (2004)
Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations
S Generini et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Treatment of recalcitrant idiopathic orbital inflammation (chronic orbital myositis) with infliximab
JA Garrity et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2004)
The presence of citrullinated proteins is not specific for rheumatoid synovial tissue
ER Vossenaar et al.
ARTHRITIS AND RHEUMATISM (2004)
Spondyloarthropathies: ankylosing spondylitis and psoriatic arthritis
DL Bennett et al.
RADIOLOGIC CLINICS OF NORTH AMERICA (2004)
Localised gastrocnemius myositis in Crohn's disease
C Christopoulos et al.
CLINICAL RHEUMATOLOGY (2003)
Treatment with infliximab (Remicade) when etanercept (Enbrel) has failed or vice versa: data from the STURE registry showing that switching tumour necrosis factor alpha blockers can make sense
R van Vollenhoven et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Inflammatory bowel disease and the risk of fracture
TP Van Staa et al.
GASTROENTEROLOGY (2003)
Bone densitometry, steroids and osteoporosis
GM Blake et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2002)
High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease
J Klaus et al.
GUT (2002)
Long-term fracture risk in patients with Crohn's disease: A population-based study in Olmsted County, Minnesota
EV Loftus et al.
GASTROENTEROLOGY (2002)
Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-alpha therapy and other novel approaches
J Braun et al.
ARTHRITIS RESEARCH (2002)
The prevalence and incidence of peripheral arthritis in patients with inflammatory bowel disease, a prospective population-based study (the IBSEN study)
O Palm et al.
RHEUMATOLOGY (2001)
Treatment of spondyloarthropathies with antibodies against tumour necrosis factor α:: first clinical and laboratory experiences
J Braun et al.
ANNALS OF THE RHEUMATIC DISEASES (2000)
Fracture risk is increased in Crohn's disease, but not in ulcerative colitis
P Vestergaard et al.
GUT (2000)
Subclinical sacroiliitis in inflammatory bowel disease: A clinical and follow-up study
R Queiro et al.
CLINICAL RHEUMATOLOGY (2000)
Share Paper
